BWX Technologies Q3 revenue rises 29%, beats estimates

Reuters
Nov 04, 2025
BWX Technologies Q3 revenue rises 29%, beats estimates

Overview

  • BWX Technologies Q3 revenue of $866.3 mln beats analyst expectations

  • Adjusted EBITDA for Q3 beats analyst estimates, driven by large multi-year contracts

Outlook

  • BWX Technologies raises 2025 non-GAAP EPS guidance to $3.75-$3.80

  • Company expects 2026 adjusted EBITDA growth in low-double-digits to low-teens

  • BWX Technologies anticipates high-single-digit to low-double-digit non-GAAP EPS growth in 2026

Result Drivers

  • RECORD BACKLOG - Driven by large, multi-year special materials projects, backlog increased 119% year-over-year

  • COMMERCIAL OPERATIONS GROWTH - Revenue increased due to higher sales in commercial nuclear components, field services, and medical sales, along with contributions from Kinectrics acquisition

  • GOVERNMENT OPERATIONS - Growth driven by higher naval nuclear component production and special materials processing, partially offset by lower microreactor volumes

Key Details

Metric

Beat/Miss

Actual

Consensus Estimate

Q3 Revenue

Beat

$866.30 mln

$790.90 mln (11 Analysts)

Q3 EPS

$0.89

Q3 Net Income

$82.20 mln

Q3 Adjusted EBITDA

Beat

$151.10 mln

$142 mln (11 Analysts)

Q3 Free Cash Flow

$94.90 mln

Analyst Coverage

  • The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 8 "strong buy" or "buy", 3 "hold" and no "sell" or "strong sell"

  • The average consensus recommendation for the aerospace & defense peer group is "buy"

  • Wall Street's median 12-month price target for BWX Technologies Inc is $200.00, about 6.8% below its October 31 closing price of $213.61

  • The stock recently traded at 54 times the next 12-month earnings vs. a P/E of 41 three months ago

Press Release: ID:nBw86qp52a

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10